#stekeyma — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #stekeyma, aggregated by home.social.
-
Celltrion has received regulatory approval in New Zealand for Stekeyma, its biosimilar to Stelara, expanding access to autoimmune disease treatments in a $21.66 billion global market.
#YonhapInfomax #Celltrion #Stekeyma #Biosimilar #Ustekinumab #NewZealandApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85542 -
Celltrion has received regulatory approval in New Zealand for Stekeyma, its biosimilar to Stelara, expanding access to autoimmune disease treatments in a $21.66 billion global market.
#YonhapInfomax #Celltrion #Stekeyma #Biosimilar #Ustekinumab #NewZealandApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85542 -
Celltrion has received regulatory approval in New Zealand for Stekeyma, its biosimilar to Stelara, expanding access to autoimmune disease treatments in a $21.66 billion global market.
#YonhapInfomax #Celltrion #Stekeyma #Biosimilar #Ustekinumab #NewZealandApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85542 -
Celltrion has received regulatory approval in New Zealand for Stekeyma, its biosimilar to Stelara, expanding access to autoimmune disease treatments in a $21.66 billion global market.
#YonhapInfomax #Celltrion #Stekeyma #Biosimilar #Ustekinumab #NewZealandApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85542